FDA's new global cardiovascular registry to start with transcatheter heart valves

April 3, 2013 by Arezu Sarvestani

The FDA announces a public meeting to discuss international cooperation in monitoring and assessing cardiovascular medical devices, with an initial pilot phase to focus on transcatheter heart valves.

FDA logo

The FDA plans to launch a global cardiovascular medical device registry, with initial efforts to focus on coordinated efforts to monitor transcatheter heart valve technology.

The federal watchdog agency will host a public meeting later this month to discuss goals and strategies for organizing such an effort, which the FDA is calling the "International Consortium of Cardiovascular Registries."

Get the complete picture with a MassDevice Plus membership. Registered users can login here.